スポンサーリンク
Department of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology | 論文
- Pancreatic Endocrine Dysfunction in Rats Not Expressing the Cholecystokinin-A Receptor
- Inactive Aldehyde Dehydrogenase-2 Increased the Risk of Pancreatic Cancer Among Smokers in a Japanese Male Population
- Central Administration of Ghrelin Stimulates Pancreatic Exocrine Secretion via the Vagus in Conscious Rats
- Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism
- Central Orexin-A Stimulates Pancreatic Exocrine Secretion via the Vagus
- Amylase Secretion from Dispersed Human Pancreatic Acini : Neither Cholecystokinin A Nor Cholecystokinin B Receptors Mediate Amylase Secretion In Vitro
- Entrainment Function in the Suprachiasmatic Nucleus of Streptozotocin-Induced Diabetic Rats
- Induction of Acute Pancreatitis by Cerulein in Human IL-6 Gene Transgenic Mice
- CHANGES IN THE PITUITARY - TESTICULAR AXIS FUNCTION DURING AGING IN NON - INSULIN DEPENDENT DIABETES MELLITUS RATS
- Cholecystokinin and cholecystokinin receptors
- Regulation of Gene Expression of Pancreatic Secretory Trypsin Inhibitor-61 and -56 by Bile and Pancreatic Juice in Rats
- Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA
- Pathophysiology of naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats
- Promoter analysis of human cholecystokinin type-A receptor gene
- Is the OLETF Rat a Good Model of Central Sensitization?
- EFFECT OF HEMATOCRIT AND VISCOSITY ON CORONARY CIRCULATION AND MYOCARDIAL OXYGEN UTILIZATION
- Oral Administration of a Synthetic Trypsin Inhibitor Increases Pancreatic Duct Function in CCK-A Receptor-Deficient Rats
- Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction
- Acute eosinophilic pneumonia caused by cigarette smoking
- Efficacy of a New Formulation of Lenograstim (Recombinant Glycosylated Human Granulocyte Colony-Stimulating Factor) Containing Gelatin for the Treatment of Neutropenia After Consolidation Chemotherapy in Patients With Acute Myeloid Leukemia